Sun Acquisitions

FEBRUARY 24, 2023

With more than 3,500 advisory firms and over 2,000 corporate buyers, Axial ranks advisory firms based on close rates of businesses listed on their platform and not a self-reported performance which may include private sales. “With over 20 years of experience, we have successfully completed over 450 transactions. .

Middle Market 52

Middle Market Acquisitions Mergers and Acquisitions Advisory 52

Chesapeake Corporate Advisors

OCTOBER 24, 2022

(“Rendia”), a provider of subscription-based point-of-care engagement software and content for eye care practitioners, in its sale to PatientPoint ® (“PatientPoint”), provider of an industry-leading, tech-enabled point-of-care network that engages healthcare providers and patients across 20 medical specialties.

Advisory 52

Advisory Investment Banking Corporation Healthcare 52

Mergers and Inquisitions

OCTOBER 16, 2024

But most coverage suggests generic answers about wanting to learn a lot, liking financial analysis or valuation, or wanting to “understand different industries.” I liked the valuation work and enjoyed meeting a few alumni bankers at firms like [Firm Names] , and I’m interested in working on the types of deals the alumni discussed.”

Investment Banking 111

Investment Banking Banking Bank Investment 111

Periculum Capital

MARCH 11, 2022

(“SHHS” “Company”), a leading home healthcare service provider, in its sale to Fortis Home Health and Hospice, LLC (“Fortis”), a portfolio company of Grant Avenue Capital, LLC (“Grant Avenue”). The firm was founded in 1998 to provide sophisticated financial advisory and transaction services.

Sale 52

Sale IT Healthcare Capital 52

iMerge Advisors

APRIL 8, 2025

Whether you're responding to inbound interest, planning a strategic exit, or exploring liquidity options, the process requires careful orchestration from valuation and positioning to buyer outreach and deal structuring. A well-prepared company signals professionalism and reduces perceived risk both of which drive valuation.

M&A 40

M&A Valuation Private Equity Negotiation 40

Sun Acquisitions

FEBRUARY 6, 2023

provides sustainable environmental solutions in the areas of Life Sciences, Healthcare, Education, and Industrial Markets. We work with clients that are interested in the confidential sale, acquisition, or valuation of privately held companies. Founded in 1988, Triumvirate Environmental Inc.

Sale 52

Sale Acquisitions Mergers and Acquisitions Manufacturing 52

Sun Acquisitions

FEBRUARY 6, 2023

MSP is a portfolio company of Persistence Capital Partners, the leading private equity fund exclusively focused on high-growth opportunities in the healthcare field. We work with clients that are interested in the confidential sale, acquisition, or valuation of privately held companies.

Sale 52

Sale Acquisitions Mergers and Acquisitions Medical 52

Solganick & Co.

MARCH 11, 2022

has been named by Axial as a top software M&A advisory firm. “Public market software company valuations have been battered starting in November of 2021. As a result, acquisition interest in smaller software companies supporting these technology-driven trends hit record highs, often with equally record-breaking valuations.

M&A 52

M&A Middle Market Valuation Private Equity 52

Chesapeake Corporate Advisors

JANUARY 13, 2023

In the video below, CCA Managing Partner, Charlie Maskell, Director, Tim Brasel, and Managing Director, Mike Zuidema break down the CCA team, investment banking, and corporate advisory highlights from 2022.

Investment Banking 52

Investment Banking M&A Government Middle Market 52

Lake Country Advisors

AUGUST 7, 2023

For example, we have seen an increasing interest in technology and healthcare businesses, driven by advancements in these sectors and the ongoing pandemic. With our experience in healthcare, manufacturing, technology, and construction sectors, we can provide valuable insights into current and projected demand trends.

Business 96

Business Sale Negotiation Broker 96

iMerge Advisors

APRIL 10, 2025

This article outlines the key regulatory hurdles in cross-border M&A for tech companies, with a focus on how they impact deal structuring, valuation, and execution timelines. based SaaS company with healthcare data may face dual scrutiny from both CFIUS and the European Commission, requiring careful coordination and pre-deal planning.

M&A 40

M&A Valuation Acquisitions Advisory 40

Tyton Partners

NOVEMBER 28, 2023

Our focus is on early-stage companies in India and East Africa, in sectors vital for societal well-being – healthcare, climate opportunities, and fintech – all under the visionary leadership of conscious leaders. To further empower our founders, we connect them with our extensive network through our pro-bono Expert Advisory Council.

Capital 59

Capital Funds Investment Portfolio 59

Cooley M&A

JANUARY 30, 2024

As we look ahead to the 2024 proxy season (and beyond), let’s review the key 2023 trends and developments from activism playbooks, with a sharp focus on the ever-changing landscape in the technology and healthcare sectors. 10] So, what does place tech and healthcare companies in activist crosshairs? Momentum building for 2024?

Private Equity 52

Private Equity M&A Capital Investors 52

Cooley M&A

FEBRUARY 8, 2018

We find this practice particularly highlighted in the healthcare sector. According to a September 2017 Equilar study of gross-up practices for 107 mergers in the healthcare sector since 2013, 10% of the relevant companies had existing gross-ups and 15% added new gross-ups in connection with M&A transactions.

M&A 52

M&A Mergers and Acquisitions Mergers Negotiation 52

How2Exit

AUGUST 8, 2023

rn In the podcast, Chelsea Mandel, the founder of Ascension Advisory, discusses her experience in the real estate and M&A space, particularly in sale-leasebacks. rn One of the reasons why sale-leasebacks can result in a higher valuation is the creditworthiness of the operating business.

Sale 130

Sale Mergers and Acquisitions Business M&A 130

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. 2022 was the busiest year for activism in the past four years, and the healthcare and life sciences industry was no exception.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Growth Business

MARCH 1, 2024

Capital is available, valuations have started to normalise and the debt markets are still supportive – albeit with greater scrutiny and higher costs. This meant that when it came to it, the thorny issue of valuation was well thought through and understood by all parties. Our discussions led to Bridges investing £8.5

Private Equity 59

Private Equity Equities Investment Business 59

How2Exit

JULY 13, 2023

The criteria include factors such as valuation multiples, legal issues, availability of buyers, ESG focus, maturity, and competition. In this case, the chocolate industry, dental, and home healthcare were among the top-ranking industries. Therefore, the net profit of $200,000 should be the basis for valuation.

Business 130

Business Collaboration Mergers and Acquisitions Valuation 130

Focus Investment Banking

MARCH 7, 2025

Private equity investments in healthcare provider practices are getting more mature and changing the way buyers and sellers approach transactions. Most of these healthcare verticals, where private equity platforms have been largely established, are entering a more mature stage now, leading to a slower rate of completed add-on deals.

Healthcare 52

Healthcare Private Equity Equities Professional Services 52

Mergers and Inquisitions

MARCH 5, 2025

While plenty of bankers and equity research professionals from healthcare teams enter biotech hedge funds, people with advanced degrees (M.D., In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. also find their way into the industry.

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64